IO Biotech, Inc. - Common Stock, par value $0.001 per share (IOBT)
CUSIP: 449778109
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 73,755,848
- Total 13F shares
- 12,982,583
- Share change
- +12,982,583
- Total reported value
- $82,349,000
- Price per share
- $6.40
- Number of holders
- 19
- Value change
- +$82,349,000
- Number of buys
- 19
Quarterly Holders Quick Answers
What is CUSIP 449778109?
CUSIP 449778109 identifies IOBT - IO Biotech, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q1 2022
Recent filing periods for CUSIP 449778109:
Top shareholders of IOBT - IO Biotech, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| HBM Healthcare Investments (Cayman) Ltd. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,690,545
|
$2,784,714 | — | 09 Nov 2021 | |
| Claus A. Andersson |
3/4/5
|
Director |
—
class O/S missing
|
1,791,490
|
$1,854,192 | — | 09 Nov 2021 | |
| Vanessa Malier |
3/4/5
|
Director |
—
class O/S missing
|
430,477
|
$445,544 | — | 09 Nov 2021 | |
| Keith A. Vendola |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
69,469
|
— | — | 04 Nov 2021 |
Institutional Holders of IO Biotech, Inc. - Common Stock, par value $0.001 per share (IOBT) as of Q4 2021
As of 31 Dec 2021,
IO Biotech, Inc. - Common Stock, par value $0.001 per share (IOBT) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,982,583 shares.
The largest 10 holders included
Novo Holdings A/S, Vivo Capital, LLC, RA CAPITAL MANAGEMENT, L.P., PFM Health Sciences, LP, Capital World Investors, Samsara BioCapital, LLC, Soleus Capital Management, L.P., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, and CAAS CAPITAL MANAGEMENT LP.
This page lists
19
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2025 Across Filers
Q3 2025 holders
21
Q4 2021 holders
19
Holder diff
-2
| Investor | Q3 2025 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.